Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Recognizing unusual skin, eye, or hair issues can help diagnose immune system disorders early, especially in children.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Hair follicles and sweat glands show different keratin staining patterns.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Clonally expanded CD8+ T cells cause alopecia areata.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

The study found that a one-step antibody method is better than the LSAB method for accurately studying hair follicle structures without false positives.

BST2 protein and certain T cells increase in early alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Innate lymphoid cells help us understand and manage allergic diseases better.

Baricitinib is effective and safe for treating severe alopecia areata.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.